zm 241385 has been researched along with Bladder, Overactive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, X; Fan, Y; Li, L; Liu, X; Lu, Q; Sun, B; Yang, Y; Zhang, H; Zhao, J; Zhu, J | 1 |
| Adam, RM; Chung, YG; Cristofaro, V; Doyle, C; Lukianov, SN; Sack, BS; Schäfer, M; Sullivan, MP | 1 |
| Chancellor, MB; de Groat, WC; Kitta, T; Kuno, S; Nonomura, K; Yoshimura, N | 1 |
3 other study(ies) available for zm 241385 and Bladder, Overactive
| Article | Year |
|---|---|
Suppression of adenosine A
Topics: Adenosine A2 Receptor Antagonists; Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cystitis; Female; Hyperalgesia; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Triazines; Triazoles; TRPV Cation Channels; Urinary Bladder; Urinary Bladder, Overactive | 2021 |
Inosine attenuates spontaneous activity in the rat neurogenic bladder through an A
Topics: Adenosine A2 Receptor Antagonists; Animals; Disease Models, Animal; Humans; Inosine; Potassium Channels; Rats; Receptor, Adenosine A2A; Spinal Cord Injuries; Sulfonamides; Triazines; Triazoles; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Xanthines | 2017 |
Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease.
Topics: Adenosine A2 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Parkinson Disease; Rats; Rats, Sprague-Dawley; Triazines; Triazoles; Urinary Bladder, Overactive; Urination | 2012 |